Search by Drug Name or NDC

    NDC 70710-1239-01 acetaZOLAMIDE 250 mg/1 Details

    acetaZOLAMIDE 250 mg/1

    acetaZOLAMIDE is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is ACETAZOLAMIDE.

    Product Information

    NDC 70710-1239
    Product ID 70710-1239_018236b7-89cf-4f06-be4d-925b4093d4b0
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name acetaZOLAMIDE
    Proprietary Name Suffix n/a
    Non-Proprietary Name acetaZOLAMIDE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name ACETAZOLAMIDE
    Labeler Name Zydus Pharmaceuticals (USA) Inc.
    Pharmaceutical Class Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA211069
    Listing Certified Through 2024-12-31

    Package

    NDC 70710-1239-01 (70710123901)

    NDC Package Code 70710-1239-1
    Billing NDC 70710123901
    Package 100 TABLET in 1 BOTTLE (70710-1239-1)
    Marketing Start Date 2023-08-04
    NDC Exclude Flag N
    Pricing Information N/A